Skip to content
Screener

KORU Medical Systems KRMD Income Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$12.05M+18.2%$11.76M+22.1%$10.9M+23.3%$10.4M+27.2%$10.19M+20.9%
$4.2M+12.9%$4.53M+26.3%$4.08M+24.5%$4.14M+38.2%$3.72M+26.1%
$7.85M+21.2%$7.23M+19.6%$6.82M+22.6%$6.26M+20.8%$6.48M+18.2%
65.1%+1.6pp61.5%-1.3pp62.6%-0.4pp60.2%-3.2pp63.5%-1.5pp
$1.07M-10.5%$1.32M+18.1%$1.14M+2.7%$933.11K-39.2%$1.19M+5.3%
$5.94M+10.3%$6.58M+10.5%$6.04M+3.7%$5.99M+16.9%$5.38M+1.2%
$7.22M+6.3%$8.1M+11.0%$7.36M+3.0%$7.13M+3.5%$6.79M+1.7%
$626.99K+301%-$864.92K+30.5%-$547.1K+65.6%-$867.68K+49.1%-$312.66K+73.8%
5.2%+8.3pp-7.4%+5.6pp-5%+13.0pp-8.3%+12.5pp-3.1%+11.1pp
$59.87K-24.2%$81K+10.7%$66.71K-17.1%$74.57K-34.0%$78.95K
-$368.74K-399%$57.85K-26.6%$64.93K+108%$89.56K-26.9%$123.14K-39.4%
$258.25K+236%-$807.08K+30.8%-$482.17K+69.1%-$778.12K+50.8%-$189.51K+80.8%
$5.8K-66.6%$4.68K+548%-$150-121%$17.36K+2,300%
$252.45K+222%-$807.08K+30.8%-$486.86K+68.8%-$777.97K+50.8%-$206.87K+79.1%
2.1%+4.1pp-6.9%+5.2pp-4.5%+13.2pp-7.5%+11.8pp-2%+9.7pp
$0.01-$0.02+33.3%-$0.11+52.2%$0.02-33.3%-$0.00-100%
$837.02K+911%-$667.39K+35.1%-$367.93K+73.3%-$663.2K+55.1%-$103.17K+89.4%
6.9%+8.0pp-5.7%+5.0pp-3.4%+12.2pp-6.4%+11.7pp-1%+10.5pp
$626.99K+301%-$864.92K+30.5%-$547.1K+65.6%-$867.68K+49.1%-$312.66K+73.8%

FAQ

What is KORU Medical Systems's revenue?
KORU Medical Systems (KRMD) generated $45.1M in revenue over the trailing twelve months, up 22.4% year over year.
Is KORU Medical Systems profitable?
KORU Medical Systems is not currently profitable: it reported a net loss of $1.8M over the trailing twelve months, a -4.0% net margin.
What are KORU Medical Systems's profit margins?
Gross margin is 62.4% and operating margin is -3.7%, with a -4.0% net margin.
What is KORU Medical Systems's earnings per share?
KORU Medical Systems's diluted EPS over the trailing twelve months is $-0.10.
Where does KORU Medical Systems's income statement data come from?
Every line is extracted from KORU Medical Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.